Please Wait
Applying Filters...
menu
    • menu
    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Your reliable CDMO partner - agile, scalable, top-quality Small Molecule API & HPAPI solutions from concept to market

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Neostigmine Methylsulfate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 9,030Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Dr. Reddy's Laboratories

    02 2American Regent

    03 2Amneal Pharmaceuticals

    04 2Amphastar Pharmaceuticals

    05 2Amring Pharma

    06 4Aurobindo Pharma Limited

    07 2Avet Pharmaceuticals

    08 1B. Braun Medical

    09 4Biological E

    10 1COOPER PHARMA

    11 2Caplin Point Laboratories Limited

    12 1EQL Pharma

    13 3Exela Pharma Sciences, LLC.

    14 8Farbe Firma

    15 3Fresenius Kabi USA

    16 2Fresenius SE & Co. KGaA

    17 2GLAND PHARMA LIMITED

    18 1Hanlim Pharmaceuticals Inc

    19 3Hikma Pharmaceuticals

    20 1JAMP PHARMA

    21 1JV Healthcare Limited

    22 1Labiana Life Sciences S.A

    23 1Lifespan Biotech

    24 2MARCAN PHARMACEUTICALS INC

    25 2Meitheal Pharmaceuticals

    26 1Mercury Laboratories

    27 2Montage Laboratories

    28 1ORIFARM GROUP AS

    29 3Omega Laboratories Limited

    30 2PH HEALTH

    31 2Pharmascience Inc.

    32 2Pluviaendo

    33 1Polifarma

    34 2REGCON HOLDINGS

    35 1SINTETICA SA

    36 2Sagent Pharmaceuticals

    37 3Themis Medicare

    38 2Umedica Laboratories

    39 1Umsebe Healthcare

    40 1Unimedic Pharma Ab

    41 3Viatris

    42 1Winston Medical Supply

    43 1Zhejiang Xianju Pharmaceutical Co. Ltd

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Dr. Reddy's Laboratories

    India
    arrow
    CPhI India
    Booth #RH.E02
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/10ML (0.5MG/ML)

    Packaging :

    Approval Date : 2018-07-10

    Application Number : 209135

    Regulatory Info : RX

    Registration Country : USA

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Dr. Reddy's Laboratories

    India
    arrow
    CPhI India
    Booth #RH.E02
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 10MG/10ML (1MG/ML)

    Packaging :

    Approval Date : 2018-07-10

    Application Number : 209135

    Regulatory Info : RX

    Registration Country : USA

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Dr. Reddy's Laboratories

    India
    arrow
    CPhI India
    Booth #RH.E02
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 3MG/3ML (1MG/ML)

    Packaging :

    Approval Date : 2022-07-06

    Application Number : 216291

    Regulatory Info : RX

    Registration Country : USA

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    American Regent

    U.S.A
    CPhI India
    Not Confirmed
    arrow

    American Regent

    U.S.A
    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/10ML (0.5MG/ML)

    Packaging :

    Approval Date : 2018-05-04

    Application Number : 209182

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    American Regent

    U.S.A
    CPhI India
    Not Confirmed
    arrow

    American Regent

    U.S.A
    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 10MG/10ML (1MG/ML)

    Packaging :

    Approval Date : 2018-05-04

    Application Number : 209182

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Amneal Pharmaceuticals

    U.S.A
    CPhI India
    Not Confirmed
    arrow

    Amneal Pharmaceuticals

    U.S.A
    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/10ML (0.5MG/ML)

    Packaging :

    Approval Date : 2018-06-15

    Application Number : 210051

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Amphastar Pharmaceuticals

    U.S.A
    CPhI India
    Not Confirmed
    arrow

    Amphastar Pharmaceuticals

    U.S.A
    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/10ML (0.5MG/ML)

    Packaging :

    Approval Date : 2017-09-25

    Application Number : 209933

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Amphastar Pharmaceuticals

    U.S.A
    CPhI India
    Not Confirmed
    arrow

    Amphastar Pharmaceuticals

    U.S.A
    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 10MG/10ML (1MG/ML)

    Packaging :

    Approval Date : 2017-09-25

    Application Number : 209933

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Avet Pharmaceuticals

    U.S.A
    CPhI India
    Not Confirmed
    arrow

    Avet Pharmaceuticals

    U.S.A
    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/10ML (0.5MG/ML)

    Packaging :

    Approval Date : 2022-11-25

    Application Number : 208230

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Avet Pharmaceuticals

    U.S.A
    CPhI India
    Not Confirmed
    arrow

    Avet Pharmaceuticals

    U.S.A
    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 10MG/10ML (1MG/ML)

    Packaging :

    Approval Date : 2022-11-25

    Application Number : 208230

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    11

    Exela Pharma Sciences, LLC.

    U.S.A
    CPhI India
    Not Confirmed
    arrow

    Exela Pharma Sciences, LLC.

    U.S.A
    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : BLOXIVERZ

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/10ML (0.5MG/ML)

    Packaging :

    Approval Date : 2013-05-31

    Application Number : 204078

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    12

    Exela Pharma Sciences, LLC.

    U.S.A
    CPhI India
    Not Confirmed
    arrow

    Exela Pharma Sciences, LLC.

    U.S.A
    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : BLOXIVERZ

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 10MG/10ML (1MG/ML)

    Packaging :

    Approval Date : 2013-05-31

    Application Number : 204078

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    13

    Exela Pharma Sciences, LLC.

    U.S.A
    CPhI India
    Not Confirmed
    arrow

    Exela Pharma Sciences, LLC.

    U.S.A
    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : BLOXIVERZ

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/5ML (1MG/ML)

    Packaging :

    Approval Date : 2023-10-27

    Application Number : 204078

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    14

    Fresenius Kabi USA

    U.S.A
    CPhI India
    Not Confirmed
    arrow

    Fresenius Kabi USA

    U.S.A
    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/10ML (0.5MG/ML)

    Packaging :

    Approval Date : 2015-01-08

    Application Number : 203629

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    15

    Fresenius Kabi USA

    U.S.A
    CPhI India
    Not Confirmed
    arrow

    Fresenius Kabi USA

    U.S.A
    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 10MG/10ML (1MG/ML)

    Packaging :

    Approval Date : 2015-01-08

    Application Number : 203629

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    16

    Fresenius Kabi USA

    U.S.A
    CPhI India
    Not Confirmed
    arrow

    Fresenius Kabi USA

    U.S.A
    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 3MG/3ML (1MG/ML)

    Packaging :

    Approval Date : 2018-09-18

    Application Number : 203629

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    17

    Hikma Pharmaceuticals

    United Kingdom
    CPhI India
    Not Confirmed
    arrow

    Hikma Pharmaceuticals

    United Kingdom
    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/10ML (0.5MG/ML)

    Packaging :

    Approval Date : 2015-12-28

    Application Number : 207042

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    18

    Hikma Pharmaceuticals

    United Kingdom
    CPhI India
    Not Confirmed
    arrow

    Hikma Pharmaceuticals

    United Kingdom
    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 10MG/10ML (1MG/ML)

    Packaging :

    Approval Date : 2015-12-28

    Application Number : 207042

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    19

    PH HEALTH

    Country
    CPhI India
    Not Confirmed
    arrow

    PH HEALTH

    Country
    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/10ML (0.5MG/ML)

    Packaging :

    Approval Date : 2017-04-26

    Application Number : 208405

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    20

    PH HEALTH

    Country
    CPhI India
    Not Confirmed
    arrow

    PH HEALTH

    Country
    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 10MG/10ML (1MG/ML)

    Packaging :

    Approval Date : 2017-04-26

    Application Number : 208405

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF